We are live on
!
Find out more
RI
RTW Investments Portfolio holdings
AUM
$10B
1-Year Est. Return
135.35%
This Fund
S&P 500
This Quarter
Est. Return
+30.25%
1 Year Est. Return
+135.35%
3 Year Est. Return
+383.62%
5 Year Est. Return
+523.94%
10 Year Est. Return
+15,981.64%
AUM
$574M
AUM Growth
+$99.8M
(+21%)
Cap. Flow
-$7.21M
Cap. Flow
% of AUM
-1.26%
Top 10 Holdings %
Top 10 Hldgs %
75.45%
Holding
31
New
3
Increased
10
Reduced
12
Closed
4
Top Buys
| 1 |
ACHN
Achillion Pharmaceuticals
ACHN
|
+$27.7M |
| 2 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$8.1M |
| 3 |
Regenxbio
RGNX
|
+$5.99M |
| 4 |
PTC Therapeutics
PTCT
|
+$3.74M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$3.09M |
Top Sells
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$35.6M |
| 2 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
+$10.8M |
| 3 |
Atara Biotherapeutics
ATRA
|
+$7.79M |
| 4 |
Omeros
OMER
|
+$4.73M |
| 5 |
Universal Health Services
UHS
|
+$3.15M |
Sector Composition
| 1 | Healthcare | 96.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Alnylam Pharmaceuticals
ALNY
$37.8B
| $73.2M | 12.75% |
623,338
-417,269
| -40% | -$35.6M |
|
|
2
PTC Therapeutics
PTCT
$6.51B
| $69.9M | 12.18% |
3,495,143
+190,929
| +6% | +$3.74M |
|
|
3
Bristol-Myers Squibb
BMY
$124B
| $52.7M | 9.19% |
827,512
+52,837
| +7% | +$3.09M |
|
|
4
Regenxbio
RGNX
$579M
| $50.7M | 8.83% |
1,539,005
+266,235
| +21% | +$5.99M |
|
|
AVXS
5
DELISTED
AveXis, Inc. Common Stock
AVXS
| $45.2M | 7.88% |
467,667
-119,450
| -20% | -$10.8M |
|
|
LJPC
6
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $36.3M | 6.33% |
1,044,307
-63,072
| -6% | -$2.03M |
|
|
ACHN
7
DELISTED
Achillion Pharmaceuticals
ACHN
| $35.2M | 6.13% |
7,839,766
+6,249,312
| +393% | +$27.7M |
|
8
Arbutus Biopharma
ABUS
$936M
| $32.7M | 5.69% |
5,266,280
+56,457
| +1% | +$241K |
|
|
AGEN
9
Agenus
AGEN
$208M
| $18.6M | 3.24% |
214,934
-3,002
| -1% | -$243K |
|
|
CORI
10
DELISTED
Corium International, Inc.
CORI
| $18.6M | 3.23% |
1,675,479
+43,478
| +3% | +$385K |
|
11
BioCryst Pharmaceuticals
BCRX
$2.32B
| $17.4M | 3.03% |
3,324,705
-9,253
| -0.3% | -$47.4K |
|
|
OXFD
12
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $17.3M | 3.02% |
1,032,370
+185,453
| +22% | +$3.02M |
|
|
BLUE
13
DELISTED
bluebird bio
BLUE
| $14.3M | 2.49% |
8,035
-23
| -0.3% | -$32.1K |
|
14
OraSure Technologies
OSUR
$273M
| $12.1M | 2.1% |
535,707
-52,549
| -9% | -$1.06M |
|
|
DRNA
15
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $12M | 2.08% |
2,078,991
| – | – |
|
16
Tactile Systems Technology
TCMD
$663M
| $10.9M | 1.9% |
353,216
-19,086
| -5% | -$604K |
|
|
MYOK
17
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $10.9M | 1.9% |
+253,962
| New | +$8.1M |
|
|
18
Atara Biotherapeutics
ATRA
$78.6M
| $10.9M | 1.89% |
26,241
-20,669
| -44% | -$7.79M |
|
|
MASI
19
DELISTED
Masimo
MASI
| $10.5M | 1.82% |
120,900
+20,000
| +20% | +$1.77M |
|
|
VIVE
20
DELISTED
VIVEVE MED INC
VIVE
| $7.72M | 1.34% |
1,473
+234
| +19% | +$1.44M |
|
|
VRAY
21
DELISTED
ViewRay, Inc.
VRAY
| $5.88M | 1.02% |
1,020,462
+256,127
| +34% | +$1.44M |
|
|
FSTX
22
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $4.2M | 0.73% |
62,274
-226
| -0.4% | -$12.9K |
|
23
Apyx Medical
APYX
$183M
| $3.85M | 0.67% |
+1,139,600
| New | +$2.94M |
|
|
ZYNE
24
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $1.67M | 0.29% |
+200,000
| New | +$2.11M |
|
|
GBT
25
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $817K | 0.14% |
26,310
-67
| -0.3% | -$1.88K |
|
Similar funds
BEI
MG
LWCFA
HRCM
RA
VNIM
OAM
GI